Skip to content

Renal Replacement Therapy and In-Hospital Mortality Incidence in Cardiac Surgery Associated Acute Kidney Injury

The Need of Renal Replacement Therapy and In-Hospital Mortality Incidence In Patients With Cardiac Surgery Associated Acute Kidney Injury: Retrospective Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06091982
Enrollment
1113
Registered
2023-10-23
Start date
2023-10-01
Completion date
2024-06-30
Last updated
2024-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Kidney Injury

Keywords

Acute Kidney Injury (AKI), Cardiac Surgery, Renal Replacement Therapy, Mortality

Brief summary

The goal of this study is to analyse the relation of severe acute kidney injury post cardiac surgery which characterised by the need of renal replacement therapy, with in-hospital postoperative mortality incidence. The main question it aims to answer: To compare between patients complicated with acute kidney injury and exposure of renal replacement therapy (AKI-RRT) and patients complicated with acute kidney injury which does not require renal replacement therapy, in associated with in-hospital postoperative mortality.

Detailed description

Type of study: observational study Participant population: Post cardiac surgery patients with condition of acute kidney injury postoperative, will be assigned into 2 groups, based on their exposure to renal replacement therapy. Those groups are: Group AKI-RRT : patients with AKI postoperative with exposure of renal replacement therapy Group AKI non RRT : patients with AKI postoperative, with no exposure to renal replacement therapy Researchers will compare group AKI-RRT and AKI non RRT to analyse the association to postoperative mortality, and other factors that related to mortality variable.

Interventions

PROCEDURERenal Replacement Therapy (RRT)

Renal Support therapy which consist of procedure of intermittent hemodialysis (IHD) or continuous veno-venous hemofiltration/hemodialysis/hemodiafiltration (CVVH/CVVHD/CVVHDF)

Sponsors

National Cardiovascular Center Harapan Kita Hospital Indonesia
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
OTHER

Eligibility

Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

1. Patients who are at least 18 years old, underwent cardiac surgery in Harapan Kita National Cardiovascular Center from January 2020 to December 2022. 2. Patients with condition was complicated with Acute Kidney Injury (AKI) which was characterised by an increase in serum creatinine \> 0.3 mg/dL or \> 150% of the preoperative serum creatinine value, which was checked within 12 hours post-operative. 3. All patients' data is recorded in the medical records unit.

Exclusion criteria

1. Patients with previous history of dialysis or renal failure in dialysis. 2. Incomplete or loss of patients' data.

Design outcomes

Primary

MeasureTime frameDescription
MortalityFrom ICU admission postoperative until the death date during hospital care, assessed up to 3 monthsNumber of participants who died of any cause during postoperative care in hospital

Secondary

MeasureTime frameDescription
ICU Stay Over 5 DaysTime of ICU length of stay measured with days, up to 4 weeksNumber of participants which the postoperative ICU length of stay more than 5 days
Mechanical Ventilation > 48 HoursTime of ventilator usage measure with hours, up to 4 weeksNumber of participants which the postoperative usage of mechanical ventilation (breathing ventilator) more than 48 hours

Countries

Indonesia

Participant flow

Recruitment details

all adult cardiac surgery patients (\> 18 years old) with EMRs who were admitted to the cardiac surgery ICU from January 1st , 2020 to December 31st, 2022

Pre-assignment details

2.670 patients excluded due to incomplete/missing reports/data, with previous RRT before surgery, and not complicated with CSA-AKI

Participants by arm

ArmCount
AKI RRT
Post cardiovascular surgery patients with condition of acute kidney injury postoperative; and with an exposure of renal replacement therapy (intermittent haemodialysis or continuous renal replacement therapy) which is indicated postoperatively.
302
AKI Non RRT
Post cardiovascular surgery patients with condition of acute kidney injury postoperative; but without exposure of renal replacement therapy.
811
Total1,113

Baseline characteristics

CharacteristicAKI RRTTotalAKI Non RRT
Age, Customized
> 60 years old
196 Participants415 Participants219 Participants
Creatinine level > 3.0 mg/dL81 Participants132 Participants51 Participants
Diabetes121 Participants361 Participants240 Participants
History of stroke118 Participants433 Participants315 Participants
Hypertension118 Participants433 Participants315 Participants
Postoperative diuretic therapy217 Participants807 Participants590 Participants
Race and Ethnicity Not Collected0 Participants
Renal disease10 Participants17 Participants7 Participants
Sex: Female, Male
Female
81 Participants251 Participants170 Participants
Sex: Female, Male
Male
221 Participants862 Participants641 Participants
Smoker62 Participants194 Participants132 Participants
Type of Surgery
CABG
118 Participants543 Participants425 Participants
Type of Surgery
Congenital
14 Participants53 Participants39 Participants
Type of Surgery
Mixed Valves
38 Participants104 Participants66 Participants
Type of Surgery
Other surgeries
49 Participants114 Participants65 Participants
Type of Surgery
Valves
83 Participants299 Participants216 Participants
Use of inotropes and vasoactives > 2 drugs129 Participants280 Participants151 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
96 / 30234 / 811
other
Total, other adverse events
129 / 302151 / 811
serious
Total, serious adverse events
104 / 30246 / 811

Outcome results

Primary

Mortality

Number of participants who died of any cause during postoperative care in hospital

Time frame: From ICU admission postoperative until the death date during hospital care, assessed up to 3 months

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
AKI-RRTMortality96 Participants
AKI Non RRTMortality34 Participants
Comparison: Bivariable analysis of both groupsp-value: <0.000195% CI: [7, 16.2]Chi-squared
Comparison: Multivariable analysisp-value: <0.000195% CI: [2, 6.1]Regression, Logistic
Secondary

ICU Stay Over 5 Days

Number of participants which the postoperative ICU length of stay more than 5 days

Time frame: Time of ICU length of stay measured with days, up to 4 weeks

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
AKI-RRTICU Stay Over 5 Days183 Participants
AKI Non RRTICU Stay Over 5 Days89 Participants
p-value: <0.000195% CI: [9.1, 17.1]Chi-squared
p-value: <0.000195% CI: [2.8, 7]Regression, Logistic
Secondary

Mechanical Ventilation > 48 Hours

Number of participants which the postoperative usage of mechanical ventilation (breathing ventilator) more than 48 hours

Time frame: Time of ventilator usage measure with hours, up to 4 weeks

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
AKI-RRTMechanical Ventilation > 48 Hours198 Participants
AKI Non RRTMechanical Ventilation > 48 Hours88 Participants
p-value: <0.000195% CI: [11.3, 21.6]Chi-squared
p-value: <0.000195% CI: [3.3, 8.2]Regression, Logistic

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026